15-61854971-A-G
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_020821.3(VPS13C):c.11077-17T>C variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00191 in 1,576,614 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.011 ( 32 hom., cov: 32)
Exomes 𝑓: 0.00096 ( 30 hom. )
Consequence
VPS13C
NM_020821.3 splice_polypyrimidine_tract, intron
NM_020821.3 splice_polypyrimidine_tract, intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.978
Genes affected
VPS13C (HGNC:23594): (vacuolar protein sorting 13 homolog C) Involved in mitochondrion organization and negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization. Located in cytosol and mitochondrial outer membrane. Implicated in Parkinson's disease 23. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
?
Variant 15-61854971-A-G is Benign according to our data. Variant chr15-61854971-A-G is described in ClinVar as [Benign]. Clinvar id is 1535945.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0108 (1639/152318) while in subpopulation AFR AF= 0.0379 (1573/41558). AF 95% confidence interval is 0.0363. There are 32 homozygotes in gnomad4. There are 755 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
?
High Homozygotes in GnomAd at 30 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VPS13C | NM_020821.3 | c.11077-17T>C | splice_polypyrimidine_tract_variant, intron_variant | ENST00000644861.2 | |||
LOC124903501 | XR_007064668.1 | n.159+5499A>G | intron_variant, non_coding_transcript_variant | ||||
VPS13C | NM_017684.5 | c.10948-17T>C | splice_polypyrimidine_tract_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VPS13C | ENST00000644861.2 | c.11077-17T>C | splice_polypyrimidine_tract_variant, intron_variant | NM_020821.3 | P3 | ||||
ENST00000642740.1 | n.172+5499A>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes ? AF: 0.0106 AC: 1619AN: 152200Hom.: 30 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
1619
AN:
152200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00289 AC: 614AN: 212160Hom.: 12 AF XY: 0.00207 AC XY: 239AN XY: 115184
GnomAD3 exomes
AF:
AC:
614
AN:
212160
Hom.:
AF XY:
AC XY:
239
AN XY:
115184
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000958 AC: 1365AN: 1424296Hom.: 30 Cov.: 30 AF XY: 0.000822 AC XY: 582AN XY: 708100
GnomAD4 exome
AF:
AC:
1365
AN:
1424296
Hom.:
Cov.:
30
AF XY:
AC XY:
582
AN XY:
708100
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0108 AC: 1639AN: 152318Hom.: 32 Cov.: 32 AF XY: 0.0101 AC XY: 755AN XY: 74498
GnomAD4 genome
?
AF:
AC:
1639
AN:
152318
Hom.:
Cov.:
32
AF XY:
AC XY:
755
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 22, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at